Vijay N. Joish

Genmab (United States) — United States

Medicine · Health Sciences

27h-index3.6kcitations125works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pulmonary Hypertension Research and Treatments(16), Neuroendocrine Tumor Research Advances(15), Health Systems, Economic Evaluations, Quality of Life(15), Asthma and respiratory diseases(11), Sleep and related disorders(11)

Publications125 total

HSD98 Real-World Treatment Patterns of US Patients With Platinum-Resistant Ovarian Cancer
Value in Health·2025
2297P Higher termination rates and survival trade-offs: A 10-year review of NICE appraisals of oncology combination therapies
Annals of Oncology·2025
Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III Studies
American Journal of Clinical Dermatology·2022· 10 citedOpen Access
Changes in Carcinoid Syndrome Symptoms Among Patients Receiving Telotristat Ethyl in US Clinical Practice: Findings from the TELEPRO-II Real-World Study
Cancer Management and Research·2021· 6 citedOpen Access
Inadequate Disease Control, Treatment Dissatisfaction, and Quality-of-Life Impairments Among US Patients Receiving Topical Therapy for Atopic Dermatitis
Dermatology and Therapy·2021· 19 citedOpen Access
333 Atopic dermatitis: Patient characteristics and patient-reported outcomes on topical therapy
Journal of Investigative Dermatology·2021
Tumor burden in serotonin secreting pancreatic neuroendocrine tumors after initiating telotristat ethyl.
Journal of Clinical Oncology·2021
<p>Survival and Clinical Outcomes with Telotristat Ethyl in Patients with Carcinoid Syndrome</p>
Cancer Management and Research·2020· 5 citedOpen Access
Improvement in Patient-Reported Outcomes in Adults with Type 1 Diabetes Treated with Sotagliflozin plus Insulin Versus Insulin Alone
Diabetes Technology & Therapeutics·2020· 11 citedOpen Access
<p>Antiproliferative Effects of Telotristat Ethyl in Patients with Neuroendocrine Tumors: The TELEACE Real-World Chart Review Study</p>
Cancer Management and Research·2020· 17 citedOpen Access
MON-630 Elevating the Patient Voice in Type 1 Diabetes Clinical Trials: A Comparison of In-Depth Exit Interviews and Diabetes-Specific Questionnaires
Journal of the Endocrine Society·2020· 1 citedOpen Access
Clinical Benefits of Telotristat Ethyl in Patients With Neuroendocrine Tumors and Low Bowel Movement Frequency
Pancreas·2020· 2 cited
Estimation of Annual Health Care Costs for Adults with Type 1 Diabetes in the United States
Journal of Managed Care & Specialty Pharmacy·2020· 27 citedOpen Access
Exploring telotristat ethyl’s antiproliferative effects in patients with carcinoid syndrome (TELEACE): A real-world observational study.
Journal of Clinical Oncology·2020· 2 cited
Burden of Cardiovascular Disease in Adult Patients with Type 1 Diabetes in the US
PharmacoEconomics - Open·2020· 7 citedOpen Access
Direct costs of carcinoid syndrome diarrhea among adults in the United States
World Journal of Gastroenterology·2019· 8 citedOpen Access
Table of Contents
Clinical Therapeutics·2019Open Access
Insights Into Patients' Experience With Type 1 Diabetes: Exit Interviews From Phase III Studies of Sotagliflozin
Clinical Therapeutics·2019· 11 cited
Work productivity burden and indirect costs associated with carcinoid syndrome diarrhea
Expert Review of Pharmacoeconomics & Outcomes Research·2019· 4 cited
Burden of Carcinoid Heart Disease in Patients With Carcinoid Syndrome Initiating Somatostatin Analogues
Clinical Therapeutics·2019· 5 cited
page 1 of 7Next →

Frequent Co-authors

Howard G. Birnbaum(6), Pablo Lapuerta(6), Noam Y. Kirson(5), Gianluca Pirozzi(4), Laurent Eckert(4), Neil M.H. Graham(4), Nikhil Amin(4), Asif Khan(4), Gary M. Oderda(4), Diana Brixner(4), Ariel Teper(3), Leda Mannent(3), Joaquim Mullol(3), Peter W. Hellings(3), Claus Bachert(3), Jasmina Ivanova(3), Tracy Waldman(3), Todd Williamson(3), Christopher L. Drake(3), Rajesh Balkrishnan(3)